Travere Therapeutics Inc.
TVTX | NASDAQ
$61.07
-$1.79 (-2.85%)
Sep 22, 2026, 12:24 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -71.9M | -36.6M | -21.99M | 25.71M | -12.76M | -41.23M | -60.27M | -54.75M | -69.65M | -136.06M | -88.6M | -89.24M | -112.17M | -86.33M | -65.82M | -102.83M | -67.03M | -75.97M | -51.57M | -35.64M | -39.01M | -53.87M |
Depreciation & Amortization | 29.45M | 25.21M | 18.14M | 15.79M | 14.02M | 12.8M | 12.09M | 11.24M | 10.35M | 9.88M | 11.85M | 11.48M | 10.95M | 6.62M | 9.3M | -793K | 8.11M | 7.09M | 6.05M | 7.87M | 6.62M | 6.07M |
Stock-Based Compensation | 37.93M | 16.15M | 11.46M | 11.26M | 10.65M | 11.49M | 9.21M | 8.02M | 9.92M | 9.76M | 8.14M | 11.32M | 11.31M | 13.47M | 9.53M | 8.02M | 12.64M | 8.19M | 8.58M | 6.99M | 7.3M | 7.91M |
Other Working Capital | 4.62M | -25.34M | 16.57M | 7.74M | -4.42M | -11.85M | 8.7M | -2.83M | -66.78M | 25.27M | 20.17M | -5.07M | 909K | -15.56M | -195K | 3.25M | 6.22M | -8.91M | 18.38M | 39.88M | 1.73M | 3.3M |
Other Non-Cash Items | 38.84M | -4K | 397K | -1.11M | -1.29M | -1.57M | -4.16M | -278K | 69.88M | 364K | 100.45M | 12.21M | 27.21M | 6.2M | -6.19M | 43.58M | 5.5M | 16.7M | -6.54M | 16.84M | 4.27M | 10.31M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -109.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.44M | n/a | 170K | 1.45M |
Change in Working Capital | -16.62M | -45.12M | 52.67M | -37.33M | -5.64M | -23.69M | 7.4M | -6.74M | -60.74M | -2.95M | 7.1M | -4.9M | -6.6M | -21.08M | -1.46M | 12.5M | 3.98M | -11.32M | 15.17M | 36.01M | 27.15M | 1.65M |
Operating Cash Flow | 17.71M | -40.37M | 60.68M | 14.32M | 4.98M | -42.19M | -35.72M | -42.51M | -40.24M | -119.01M | -70.47M | -59.13M | -69.3M | -81.12M | -54.64M | -39.53M | -36.81M | -55.32M | -26.88M | 32.06M | 6.5M | -26.47M |
Capital Expenditures | n/a | -22.18M | -18.86M | -140K | -235K | -11.78M | -9.56M | -8.19M | -11.99M | -6.47M | -5.53M | -10K | -3.2M | -27.97M | -30K | -13K | -17K | -5.27M | -5.2M | -349K | -4.31M | -9.27M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.65M | n/a | 3.2M | 27.34M | n/a | n/a | n/a | 5.14M | 14M | n/a | 4.2M | 4.78M |
Purchase of Investments | n/a | -5.06M | -167.93M | -4.85M | -64.37M | n/a | -125.76M | n/a | n/a | n/a | -62.65M | -155.63M | -122.47M | -103.19M | -84.29M | -94.58M | -180.25M | -26.28M | -44.94M | -96.14M | -157.17M | -248.84M |
Sales Maturities Of Investments | 85.15M | 48.78M | 82.42M | 106.62M | 81.4M | 53.16M | 55.05M | 54.32M | 105.6M | 111.36M | 50M | 87.7M | 102.75M | 94.12M | 52.38M | 112.29M | 152.61M | 64.72M | 57.51M | 134.04M | 89.67M | 152.4M |
Other Investing Acitivies | -269.89M | n/a | -470K | 3K | -11.94M | -83K | -40K | n/a | -76.91M | 104.9M | -11.42M | 206.17M | -3.84M | -27.34M | -600K | -7.62M | -11.44M | -5.14M | -14M | -5.03M | -4.2M | -4.78M |
Investing Cash Flow | -184.74M | 21.55M | -104.84M | 86.59M | 4.85M | 41.29M | -80.31M | 46.13M | 28.61M | 104.9M | -16.95M | 133.32M | -23.55M | -37.04M | -36.7M | 10.08M | -39.1M | 33.17M | 7.37M | 32.52M | -71.81M | -105.71M |
Debt Repayment | 174.12M | n/a | n/a | -68.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -394K | 95.44M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -14.96M | -525K | -525K | -525K | -525K | -525K | -525K | -525K | -525K | -525K | -784K | -785K | 2.27M | 25.8M | -1.13M | -1.13M | -1.13M | -1.07M | 2.44M | -1.19M | 402K | 1.5M |
Financial Cash Flow | 191.72M | 4.2M | 26.68M | -65.34M | 1.48M | 3.72M | 139.12M | 46K | 782K | -525K | 124K | -634K | 2.27M | 217M | 551K | 2.28M | 831K | 113.91M | 33.21M | 2.41M | 303K | 195.75M |
Net Cash Flow | 24.7M | -14.67M | -17.9M | 35.78M | 13.26M | 3.36M | 22.13M | 4.12M | -10.96M | -14.93M | -86.07M | 73.37M | -90.5M | 99.69M | -89.65M | -28.42M | -76.81M | 90.82M | 15.43M | 67.04M | -64.94M | 63.46M |
Free Cash Flow | 17.71M | -62.54M | 41.81M | 14.18M | 4.75M | -53.98M | -45.28M | -50.7M | -52.24M | -125.47M | -76M | -59.14M | -72.5M | -109.08M | -54.67M | -39.54M | -36.82M | -60.59M | -32.08M | 31.71M | 2.19M | -35.74M |
Adj. Free Cash Flow | -20.23M | -78.69M | 30.35M | 2.91M | -5.9M | -65.47M | -54.5M | -58.72M | -62.16M | -135.23M | -84.15M | -70.47M | -83.81M | -122.56M | -64.2M | -47.56M | -49.46M | -68.77M | -40.65M | 24.73M | -5.11M | -43.65M |
Maintenance CapEx | n/a | -22.18M | -13.56M | n/a | n/a | -7.88M | -6.17M | -5.25M | -9.49M | -6.47M | -5.53M | n/a | -3.2M | -27.06M | -30K | -13K | -17K | -5.17M | -4.83M | n/a | -3.94M | -9.27M |
Growth CapEx | n/a | n/a | -5.31M | -140K | -235K | -3.9M | -3.39M | -2.94M | -2.5M | n/a | n/a | -10K | n/a | -910.74K | n/a | n/a | n/a | -93.68K | -373.02K | -349K | -368.31K | n/a |
Owner Earnings | 17.71M | -62.54M | 47.12M | 14.32M | 4.98M | -50.08M | -41.89M | -47.76M | -49.74M | -125.47M | -76M | -59.13M | -72.5M | -108.17M | -54.67M | -39.54M | -36.82M | -60.49M | -31.7M | 32.06M | 2.56M | -35.74M |
Add to Watchlist
Select watchlists to add or remove TVTX